Evidence map›Paper›PMID 42467393›Full record

ArticleBreast cancer (Tokyo, Japan)2026

Initial activities and prospects of MIRAY1: a youth-driven, society-endorsed initiative to cultivate future breast cancer physicians.

Hiroko Masuda, Takaaki Konishi, Mai Onishi, Aki Ito, Kazunoshin Tachibana, Akari Murakami, Atsushi Fushimi, Ryota Otsubo, Haruru Kotani, Yuri Kimura and 20 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Breast cancer (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

Hiroko Masuda *Department of Breast Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan. hiroko_masuda@tmhp.jp.ORCID http://orcid.org/0000-0002-4306-1298
Takaaki Konishi *Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Mai OnishiDana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA.
Aki ItoDepartment of Breast Surgery, Akita Red Cross Hospital, 222-1 Saruta-Nawashirosawa, Kamikitate, Akita-shi, Akita, 010-1495, Japan.
Kazunoshin TachibanaDepartment of Breast Surgery, Fukushima Medical University, 1 Hikarigaoka, Fukushima-shi, Fukushima, 960-1295, Japan.
Akari MurakamiDepartment of Breast Center, Ehime University Hospital, 454 Shitsugawa, Toon-shi, Ehime, 791-0295, Japan.
Atsushi FushimiDivision of Breast and Endocrine Surgery, Department of Surgery, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo, 105-8461, Japan.
Ryota OtsuboDepartment of Surgery, Breast and Endocrine Surgery, Nagasaki University, 1-7-1 Sakamoto, Nagasaki-shi, 852-8501, Nagasaki, Japan.
Haruru KotaniDepartment of Breast Oncology, Aichi Cancer Center, 1-1 Kanokoden, Chikusa-ku, Nagoya-shi, 464-8681, Aichi, Japan.
Yuri KimuraBreast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Yuka InoueBreast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Yukinori OzakiBreast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Kaori TaneDepartment of Breast Surgery, Hyogo Cancer Center, 13-70 Kitaoji, Akashi, 673-0021, Hyogo, Japan.
Tsutomu IwasaDepartment of Medical Oncology, Kindai Nara Hospital, 1248-1 Otoda-cho, Ikoma City, 630-0293, Nara, Japan.
Yuko TakahashiDepartment of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama-shi, 700-8558, Okayama, Japan.
Yuko KanemotoDepartment of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita-shi, 565-0871, Osaka, Japan.
Yurika IidaDepartment of Surgery, Takaoka City Hospital, 4-1 Takara-machi, Takaoka-shi, 933-8550, Toyama, Japan.
Chiaki KudoDepartment of Thoracic and Breast Surgery, Akita Kousei Medical Center, 1-1-1 Iijima Nishibukuro, Akita-shi, 011-0948, Akita, Japan.
Sayuka NakayamaDepartment of Surgery, Division of Breast Surgery, Graduate School of Medicine, Showa Medical University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
Takahiro SuzukiDepartment of Breast Surgery, Hirosaki General Medical Center, 1 Tomino-cho, Hirosaki-shi, 036-8545, Aomori, Japan.
Midori MoritaDepartment of Endocrine and Breast Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto-shi, 602-8566, Kyoto, Japan.
Riko SatoDepartment of Breast-Thyroid-Endocrine Surgery, University of Tsukuba Hospital, 2- 1-1 Amakubo, Tsukuba-shi, 305-8576, Ibaraki, Japan.
Masafumi IidaDepartment of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Akihiko OzakiBreast and Thyroid Center, Jyoban Hospital of Tokiwa Foundation, 57 Kaminodai, Joban-Kamiyunagaya-machi, Iwaki-shi, 972-8322, Fukushima, Japan.
Mai KitazawaDepartment of Breast Surgery, Asahi University Hospital, 3-23 Hashimoto-cho, Gifu, 500-8856, Gifu, Japan.
Masafumi InokuchiDepartment of Breast Surgery, Breast Center, Kanazawa Medical University Hospital, 1-1 Daigaku, Uchinada-machi, Kahoku-shi, 920-0293, Ishikawa, Japan.
Chikako YamauchiDepartment of Radiation Oncology, Shiga General Hospital, 5-4-30 Moriyama, Moriyama-shi, 524-8524, Shiga, Japan.
Takanobu IshidaTohoku Kousai Hospital, 2-3-11, Kokubuncho, Aoba-ku, Sendai, 980-0803, Japan.
Norikazu MasudaDepartment of Breast Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Masakazu ToiDepartment of Breast Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the incidence of breast cancer is increasing rapidly in Japan, the number of specialized physicians remains insufficient, threatening the sustainability and geographic equity of care delivery. This growing mismatch between clinical demand and workforce capacity reflects not only numerical shortages, but also structural weaknesses in training, retention, and career development pathways. To address these workforce challenges, the Japanese Breast Cancer Society launched the Multi Institutional bReast cAncer Young team No.1 (MIRAY1) as a youth-driven, society-endorsed initiative focused on recruitment, education, and career development of future breast cancer specialists. MIRAY1 employs an innovative matrix structure where members belong to both one of six task groups and one of seven regional divisions. Each task group is designed to address specific challenges identified in the current breast cancer workforce pipeline; for example, limited early exposure, attrition during early and mid-career stages, and declining international mobility. Early activities have demonstrated high engagement among medical students and young physicians through hands-on education, digital communication, and peer-led networking. MIRAY1 represents a potentially sustainable workforce development model not only for Japan but also for other Asian countries facing similar challenges in oncology care.

Indexed as

Breast NeoplasmsMedical OncologyPhysiciansCareer ChoiceFemaleHumansJapanSocieties, MedicalBreast cancerCareer developmentEducationMedical societyResidency

Identifiers

PMID42467393

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.